6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________________________________

FORM 6-K

_________________________________________________

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

January 2026

Commission File

Number: 001-04546

______________________________________________________

UNILEVER PLC

(Translation of registrant’s name into English)

_____________________________________________________

UNILEVER HOUSE, BLACKFRIARS, LONDON, ENGLAND

(Address of principal executive office)

_____________________________________________________

Indicate by check mark whether the registrant files or will file annual reports

under cover of Form 20-F or Form 40-F.

Form 20-F ☒  Form 40-F ☐

02 January 2026

Unilever PLC

Voting Rights and Capital Update

The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1.

Unilever PLC's issued share capital as at 31 December 2025 consisted of 2,181,005,247 ordinary shares of 3 1/2p each. Of those ordinary shares, no shares were held as treasury shares and 319,412 ordinary shares (including ordinary shares represented by Unilever PLC ADSs) were held by or on behalf of companies in the Unilever group (the "Unilever Group Shares"). The voting rights attaching to the Unilever Group Shares are not exercisable. Accordingly, as at 31 December 2025, there were 2,180,685,835 shares with voting rights.

The figure of 2,180,685,835 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Unilever PLC under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date 02 January 2026